Review decisions

Showing 30 results of 290 total
Summary Safety Review - Mercaptopurine - Assessing the Potential Risk of Hypoglycemia
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1683309818342
DIN(s): 00004723, 02415275
Issued / Original Publication Date: 2023-05-10
Updated Date: 2023-05-10
Summary safety review - Proglycem (diazoxide) - Assessing the Potential Risk of Pericardial Effusion
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00294
Issued / Original Publication Date: 2023-03-24
Summary safety review - Cloxacillin - Assessing the Potential Risk of Acute Kidney Injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00293
Issued / Original Publication Date: 2023-03-22
Summary Safety Review - Rocuronium - Assessing the Potential Risk of Mydriasis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00292
Issued / Original Publication Date: 2023-02-09
Summary Safety Review - Cephalosporins - Assessing the Potential Risk of Seizures
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00291
Issued / Original Publication Date: 2023-01-23
Summary Safety Review - Finasteride - Assessing the Potential Risks of Suicide, Suicidal Thoughts (Suicidal Ideation) and Self-injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00290
Issued / Original Publication Date: 2023-01-19
Summary Safety Review - Third Generation Aromatase Inhibitors (anastrozole, exemestane, letrozole) - Assessing the Potential Risk of Tendon Disorders
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00289
Issued / Original Publication Date: 2023-01-17
Summary Safety Review - Standard Synthetic Mid-urethral Sling - Assessing Long-term Safety and Effectiveness
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00288
Issued / Original Publication Date: 2022-11-14
Summary Safety Review - Xeljanz/Xeljanz XR (tofacinitib), Olumiant (baricitinib) and Rinvoq (upadacitinib) - Janus Kinase (JAK) Inhibitors - Assessing the Potential Risks of Serious Heart-related Problems, Blood Clots, Cancer and Death
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00287
Issued / Original Publication Date: 2022-09-16
Summary Safety Review - Nexavar (sorafenib) - Assessing the Potential Risk of Thrombotic Microangiopathy
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00286
Issued / Original Publication Date: 2022-08-11

Displaying 21 - 30 of 290 | Page 3 of 29
Report a problem or mistake on this page
Please select all that apply:
Date modified: